Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma-Reference-Cited by-同舟云学术

Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma

Published:2022-01-17 Issue:3 Volume:33 Page:278-285
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Polvani Simone,Martignano Filippo,Scoccianti Guido,Pasqui Adriano,Palomba Anna Rita,Conticello Silvo,Galli Andrea,Palchetti Ilaria,Caporalini Chiara,Antonuzzo Lorenzo,Campanacci Domenico Andrea,Pillozzi Serena

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference49 articles.

1. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.;Wu;Eur Rev Med Pharmacol Sci,2019

2. Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma.;Pan;Hereditas,2018

3. An integrative analysis of DNA methylation in osteosarcoma.;Xu;J Bone Oncol,2017

4. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray.;Shi;Mol Med Rep,2017

5. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.;Rosen;Cancer,1976

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GAS5: A pivotal lncRNA in diabetes mellitus pathogenesis and management;Pathology - Research and Practice;2024-01

2. Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis;Cell Division;2023-03-07

3. A systematic review and meta-analysis of long noncoding RNA 00963 expression and prognosis and clinicopathological characteristic in human cancers;Pathology - Research and Practice;2023-02

4. Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review;eLife;2022-11-03